CVS Health Corporation [CVS] stock Initiated by Loop Capital analyst, price target now $120

CVS Health Corporation [NYSE: CVS] gained 1.16% on the last trading session, reaching $91.94 price per share at the time. The company report on October 13, 2022 that Reinventing health care: The Aetna Connected Plan with CVS Health® is helping deliver cost-effective, accessible and easy health care.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


We are bringing together the Aetna Whole HealthSM network with CVS Health® services to deliver unique health care to select counties in the metro Atlanta market.

The Aetna Connected Plan with CVS Health® is a new plan offering that will deliver CVS Health® (NYSE: CVS) and Aetna® capabilities to the metro Atlanta market to help members access care when and where they need it – and at a lower cost than a traditional plan.

CVS Health Corporation represents 1.31 billion in outstanding shares, while the company has a total market value of $121.78 billion with the latest information. CVS stock price has been found in the range of $90.87 to $92.81.

If compared to the average trading volume of 5.13M shares, CVS reached a trading volume of 5657155 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about CVS Health Corporation [CVS]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $118.57 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Loop Capital have made an estimate for CVS Health Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 17, 2022. While these analysts kept the previous recommendation, Bernstein dropped their target price from $122 to $112. The new note on the price target was released on May 27, 2022, representing the official price target for CVS Health Corporation stock. Previously, the target price had yet another raise to $110, while Deutsche Bank analysts kept a Hold rating on CVS stock.

The Average True Range (ATR) for CVS Health Corporation is set at 2.65, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.40. The Price to Book ratio for the last quarter was 1.61, with the Price to Cash per share for the same quarter was set at 11.32. Price to Free Cash Flow for CVS in the course of the last twelve months was 9.31 with Quick ratio for the last quarter at 0.70.

Trading performance analysis for CVS stock

CVS Health Corporation [CVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.89. With this latest performance, CVS shares dropped by -9.96% in over the last four-week period, additionally sinking by -11.48% over the last 6 months – not to mention a rise of 8.83% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 41.97, with the RSI for the last a single of trading hit 44.21, and the three-weeks RSI is set at 42.12 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 99.19, while it was recorded at 90.01 for the last single week of trading, and 100.06 for the last 200 days.

CVS Health Corporation [CVS]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corporation [CVS] shares currently have an operating margin of +5.12 and a Gross Margin at +17.77. CVS Health Corporation’s Net Margin is presently recorded at +2.71.

Return on Equity for this stock inclined to 10.95, with Return on Assets sitting at 3.30.

CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 0.90.

CVS Health Corporation [CVS]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 6.15%.

An analysis of insider ownership at CVS Health Corporation [CVS]

There are presently around $95,045 million, or 80.30% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 114,208,329, which is approximately 2.094% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 94,478,091 shares of the stock with an approximate value of $8.69 billion in CVS stocks shares; and CAPITAL WORLD INVESTORS, currently with $5.41 billion in CVS stock with ownership of nearly 0.346% of the company’s market capitalization.

Positions in CVS Health Corporation stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 1,064 institutional holders increased their position in CVS Health Corporation [NYSE:CVS] by around 55,026,963 shares. Additionally, 1,127 investors decreased positions by around 47,117,371 shares, while 250 investors held positions by with 931,627,264 shares. The mentioned changes placed institutional holdings at 1,033,771,598 shares, according to the latest SEC report filing. CVS stock had 119 new institutional investments in for a total of 5,566,692 shares, while 137 institutional investors sold positions of 3,912,185 shares during the same period.


Please enter your comment!
Please enter your name here